Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Roche Holding AG | 1.20% | $5.44M | CHF287.83B | 46.49% | 73 Outperform | |
| HSBC Holdings | 1.00% | $4.53M | $290.53B | 54.56% | 78 Outperform | |
| Novartis | 0.91% | $4.11M | $309.51B | 54.70% | 80 Outperform | |
| ASML Holding | 0.89% | $4.02M | $539.78B | 87.16% | 81 Outperform | |
| Toyota Motor | 0.70% | $3.18M | $322.13B | 34.76% | 81 Outperform | |
| Royal Bank Of Canada | 0.70% | $3.18M | $237.50B | 42.36% | 75 Outperform | |
| Vinci SA | 0.67% | $3.04M | €75.52B | 24.38% | 76 Outperform | |
| GlaxoSmithKline | 0.62% | $2.82M | $119.30B | 62.92% | 77 Outperform | |
| UniCredit SpA | 0.62% | $2.81M | €111.11B | 69.32% | 75 Outperform | |
| SAFRAN SA | 0.61% | $2.77M | €136.93B | 34.31% | 67 Neutral |